Technology areas: Transportation, E-Commerce & Mechanical Systems • Medical Devices & Mechanical Engineering
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Point Robotics Medtech Inc. maintains a patent portfolio in the Medical Devices & Mechanical Engineering technology area. The company currently has 3 pending office actions distributed across 3 distinct examiners. This distribution indicates that each active matter is being handled by a different individual.
The prosecution activity is spread across 3 distinct art units, matching the count of pending actions and examiners. LUU, TIMOTHY TUAN is identified as the busiest examiner for the company, currently responsible for 1 pending office action. This ratio between actions and examiners prevents any examiner from overseeing multiple pending cases.
For practitioners, this data shows a prosecution landscape where the workload is split among 3 different art units. Strategies must be tailored to the specific requirements of these units, as the company has not established a concentrated presence in a administrative division. The 3 pending office actions represent the current scope of the company's engagement with the patent office.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (50%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LAWSON, MATTHEW JAMES | 1 | 73.7% | +29.9% |
| LUU, TIMOTHY TUAN | 1 | 45.7% | +38.1% |
| KAMIKAWA, TRACY L | 1 | 58.4% | +37.3% |
| BIANCAMANO, ALYSSA N | 1 | 55.9% | +36.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19300628 | SCREW IMPLANTATION DEVICE | LAWSON, MATTHEW JAMES | — |
| 17702798 | VERIFICATION BLOCK STRUCTURE AND VERIFICATION SYSTEM FOR ORTHOPEDIC SURGERY | BIANCAMANO, ALYSSA N | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19300628 | SCREW IMPLANTATION DEVICE | LAWSON, MATTHEW JAMES | — |
| 19059270 | SYSTEM AND METHOD FOR GENERATING ENDOSCOPIC IMAGE | LUU, TIMOTHY TUAN | — |
| 19021206 | AUTOMATIC SCREW IMPLANTATION SYSTEM | KAMIKAWA, TRACY L | — |
| 17702798 | VERIFICATION BLOCK STRUCTURE AND VERIFICATION SYSTEM FOR ORTHOPEDIC SURGERY | BIANCAMANO, ALYSSA N | — |
| Art Unit | Apps |
|---|---|
| 3619 | 1 |
| 3795 | 1 |
| 3775 | 1 |
| 3715 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19300628 | SCREW IMPLANTATION DEVICE | LAWSON, MATTHEW JAMES | 3619 | §102§103 | Non-Final OA | — | Pending | Aug 14, 2025 |
| 19059270 | SYSTEM AND METHOD FOR GENERATING ENDOSCOPIC IMAGE | LUU, TIMOTHY TUAN | 3795 | §103 | Non-Final OA | — | Pending | Feb 21, 2025 |
| 19021206 | AUTOMATIC SCREW IMPLANTATION SYSTEM | KAMIKAWA, TRACY L | 3775 | §103 | Non-Final OA | — | Pending | Jan 15, 2025 |
| 17702798 | VERIFICATION BLOCK STRUCTURE AND VERIFICATION SYSTEM FOR ORTHOPEDIC SURGERY | BIANCAMANO, ALYSSA N | 3715 | §103§112 | Final Rejection | — | Pending | Mar 24, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial